BB
Blake Borgeson sold $242K of RXRX stock
Blake Borgeson, Dir of Recursion Pharmaceuticals, Inc. (RXRX), sold 50,000 shares of RXRX stock worth $242K, per an SEC Form 4 filed Oct 7, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 6, 2026, 1 day before it was made public.
RXRX has moved -41.3% since the trade date, from $4.63 to $2.72 (Nov 19, 2026 close).
- Traded
- Oct 6, 2026
- Disclosed
- Oct 7, 2026
- Filing delay
- 1 day
- Price since
- -41.3%
- Role
- Dir
- Source
- SEC Form 4